Pure Global
Disease/Condition
1,397 Clinical Trials
10+ Countries

Type 2 Diabetes Clinical Trials Database - Free Access to 1,397 Studies

Access comprehensive clinical trial information for Type 2 Diabetes through Pure Global AI's free database. This collection includes 1,397 clinical trials across multiple phases including N/A, Phase 3, Phase 4. Currently, 195 trials are actively recruiting participants.

Research for Type 2 Diabetes is being conducted in United States of America, China, Japan and 7+ other countries. Leading sponsors include AstraZeneca and Eli Lilly and Company. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
N/A
738
Phase 3
161
Phase 4
160
Phase 1
129
Phase 2
94
By Status
Completed
800
Recruiting
195
Not yet recruit...
146
Unknown
131
Terminated
55
Top Countries
United States of America323
China178
Japan75
Canada58
Australia46
Top Sponsors
AstraZeneca87
Eli Lilly and Comp...34
Jiangsu HengRui Me...29
Merck Sharp & Dohm...18
Novo Nordisk A/S12
Recent Trials
Latest clinical trials for Type 2 Diabetes
NCT06419816
Not yet recr...

Effect of Linking Data Using Smartphone Application, 'Well Check', on Clinical Outcomes in Patients With Type 2 Diabetes Mellitus

Daewoong Pharmaceutical Co. LT...
NCT06417489
Phase 4
Not yet recr...

Evaluation of Efficacy and Safety of Combination Therapy of Henagliflozin Proline, Retagliptin and Metformin in New Diagnosed Type 2 Diabetes Patients

Peking University First Hospit...
NCT06393348
Phase 2
Not yet recr...

Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i.

Shandong Suncadia Medicine Co....
NCT06399835
Phase 4
Recruiting

Enavogliflozin vs. Pioglitazone on Glucose and Atherosclerosis

Seoul National University Bund...South Korea
NCT06382246
Recruiting

The Acute Effect of Exercise Snacks on Glycemic Responses in Individuals With Type 2 Diabetes.

University of British ColumbiaCanada
NCT06382259
Recruiting

The Acute Effect of Low-intensity Movement Breaks on Glycemic Responses in Individuals With Type 2 Diabetes.

University of British ColumbiaCanada
NCT06407245
Recruiting

Efficacy of Exercise Snacks in Real-World Settings in Individuals Living With Type 2 Diabetes

University of British ColumbiaCanada
NCT06374186
Not yet recr...

Continuous Glucose Monitoring, Contingency Management, and Motivational Interviewing for Patients With Type 2 Diabetes in Kansas City

University of Missouri, Kansas...United States of America
NCT06331338
Recruiting

Effects of Using Decision Cycle for Person-Centered Glycemic Management in Type 2 Diabetes

National Taiwan University Hos...Taiwan
NCT06327503
Recruiting

Salivary Signal Molecules for Neural and Vascular Homeostasis in T2DM

University of BelgradeSerbia
NCT06323174
Phase 3
Recruiting

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise

Novo Nordisk A/SChina,Hungary,Italy,Poland,Saudi Arabia,Serbia,United States of America
NCT06323161
Phase 3
Recruiting

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Once-daily Basal Insulin With or Without Metformin

Novo Nordisk A/SChina,Japan,Serbia,Slovakia,South Africa,United States of America
NCT06319703
Not yet recr...

Implementing an Effective Diabetes Intervention Among Low-Income Immigrants

NYU Langone HealthUnited States of America
NCT06319716
Not yet recr...

Leveraging Videos and Community Health Workers to Address Social Determinants of Health in Immigrants

NYU Langone HealthUnited States of America
NCT06324669
Recruiting

The Effect of a Ketone Drink on Blood Glucose Levels in People With Type 2 Diabetes

University of ExeterUnited Kingdom
NCT06313164
Completed

The Impact of Oral Glutathione on Oxidative Damage and Glycated Hemoglobin (HbA1c) Levels in Type 2 Diabetes Patients

S.LAB (SOLOWAYS)Russian Federation
NCT06312553
Not yet recr...

Remotely Delivered Mindfulness-Based Diabetes Education

University of Alabama at Birmi...
NCT06304844
Not yet recr...

Risk of CKD in Diabetic Patients With MAFLD

Sohag University
NCT06297603
Phase 3
Recruiting

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

Eli Lilly and CompanyArgentina,Puerto Rico,United Kingdom,United States of America
NCT06290349
Phase 3
Not yet recr...

Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Dong-A ST Co., Ltd.South Korea
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
About Type 2 Diabetes Research

Pure Global AI provides free access to 1,397 clinical trials studying Type 2 Diabetes, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include AstraZeneca, Eli Lilly and Company, Jiangsu HengRui Medicine Co., Ltd., among others.

Quick Facts
Total Trials1,397
Countries10+
Sponsors10+
Recruiting195